Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents
| dc.contributor.author | Patruno, Ilaria | |
| dc.contributor.author | Thompson, Dawn | |
| dc.contributor.author | Dall'angelo, Sergio | |
| dc.contributor.author | Windhorst, Albert D. | |
| dc.contributor.author | Vugts, Danielle J. | |
| dc.contributor.author | Poot, Alex J. | |
| dc.contributor.author | Mody, Nimesh | |
| dc.contributor.author | Zanda, Matteo | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Cardiovascular and Diabetes Centre | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2021-07-08T23:08:24Z | |
| dc.date.available | 2021-07-08T23:08:24Z | |
| dc.date.embargoedUntil | 2021-07-09 | |
| dc.date.issued | 2020-08-19 | |
| dc.description | We thank the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement N° 675417 (PET3D project) for financial support of the project and the studentship of I.P. We also thank the British Heart Foundation for the project grant PG/16/90/32518. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1374997 | |
| dc.identifier | 171215863 | |
| dc.identifier | ccb8049e-df3b-41bd-b5e1-f9bc75f57bc7 | |
| dc.identifier | 32497314 | |
| dc.identifier | 000546405300001 | |
| dc.identifier | 85087726706 | |
| dc.identifier.citation | Patruno, I, Thompson, D, Dall'angelo, S, Windhorst, A D, Vugts, D J, Poot, A J, Mody, N & Zanda, M 2020, 'Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents', ChemMedChem, vol. 15, no. 16, pp. 1579-1590. https://doi.org/10.1002/cmdc.202000143 | en |
| dc.identifier.doi | 10.1002/cmdc.202000143 | |
| dc.identifier.iss | 16 | en |
| dc.identifier.issn | 1860-7179 | |
| dc.identifier.other | ORCID: /0000-0003-0948-9458/work/77366274 | |
| dc.identifier.other | ORCID: /0000-0002-2215-7952/work/147568357 | |
| dc.identifier.other | ORCID: /0000-0001-9377-0474/work/176747551 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16797 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85087726706&partnerID=8YFLogxK | en |
| dc.identifier.vol | 15 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | ChemMedChem | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | retinoic acid | en |
| dc.subject | Click chemistry | en |
| dc.subject | cancer | en |
| dc.subject | fluorine-18 | en |
| dc.subject | diabetes | en |
| dc.subject | metabolic syndrome | en |
| dc.subject | radiopharmaceuticals | en |
| dc.subject | R Medicine | en |
| dc.subject | Drug Discovery | en |
| dc.subject | Molecular Medicine | en |
| dc.subject | Biochemistry | en |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics(all) | en |
| dc.subject | Pharmacology | en |
| dc.subject | Organic Chemistry | en |
| dc.subject | British Heart Foundation | en |
| dc.subject | PG/16/90/32518 | en |
| dc.subject | European Commission | en |
| dc.subject | N° 675417 (PET3D project) | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Design, synthesis, radiosynthesis and biological evaluation of Fenretinide analogues as anticancer and metabolic syndromepreventive agents | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Zanda_et_al_CMC_DesignSynthesisRadioSynthesis_AAM.pdf
- Size:
- 1.31 MB
- Format:
- Adobe Portable Document Format
